Pharma firms rush to escape US tax shackles
AbbVie–Shire and Mylan–Abbott mergers both allow US firms to escape to lower-tax European countries
AbbVie–Shire and Mylan–Abbott mergers both allow US firms to escape to lower-tax European countries